Prior to joining SPS, Samir spent more than 10 years at Sandoz and Novartis, in Switzerland and France, participating to the development of analytical methods for agrochemical and pharmaceutical compounds and formulations. In 2005, he resigned from Novartis to create SPS Pharma Services which is the first and only CRO specializing in Dissolution and Release Testing. In April 2013, SPS moved to a new larger facility in Orleans (France) to provide a broader range of services to its clients, including cGMP routine testing. The facility has been successfully inspected by US FDA and is registered as Pharmaceutical Establishment for both US and Europe. Since beginning of 2022, SPS is fully integrated within SOTAX Group and Samir is now in charge of the business segment Pharma Services, which comprises of 3 sites located in Europe, America and Asia.